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Abstract. 
 
Tumor necrosis factor–
 
a
 
, interleukin-1, and 
endotoxin stimulate the expression of vascular endo-
thelial cell (EC) adhesion molecules. Here we describe 
a novel pathway of adhesion molecule induction that is 
independent of exogenous factors, but which is depen-
dent on integrin signaling and cell–cell interactions. 
Cells plated onto gelatin, fibronectin, collagen or fibrin-
ogen, or anti-integrin antibodies, expressed increased 
amounts of E-selectin, vascular cell adhesion molecule–1, 
and intercellular adhesion molecule–1. In contrast, ECs 
 
failed to express E-selectin when plated on poly-
 
l
 
-lysine 
or when plated on fibrinogen in the presence of attach-
ment-inhibiting, cyclic Arg-Gly-Asp peptides. The du-
ration and magnitude of adhesion molecule expression 
was dependent on EC density. Induction of E-selectin 
on ECs plated at confluent density was transient and re-
turned to basal levels by 15 h after plating when only 7 
 
6
 
 2% (
 
n
 
 
 
5
 
 5) of cells were positive. In contrast, cells 
plated at low density displayed a 17-fold greater expres-
sion of E-selectin than did high density ECs with 57 
 
6
 
 4% 
(
 
n
 
 
 
5
 
 5) positive for E-selectin expression 15 h after 
plating, and significant expression still evident 72 h af-
ter plating. The confluency-dependent inhibition of ex-
pression of E-selectin was at least partly mediated 
through the cell junctional protein, platelet/endothelial 
cell adhesion molecule–1 (PECAM-1). Antibodies 
against PECAM-1, but not against VE-cadherin, in-
creased E-selectin expression on confluent ECs. Co–
culture of subconfluent ECs with PECAM-1– coated 
beads or with L cells transfected with full-length PE-
CAM-1 or with a cytoplasmic truncation PECAM-1 
mutant, inhibited E-selectin expression. In contrast, un-
transfected L cells or L cells transfected with an adhe-
sion-defective domain 2 deletion PECAM-1 mutant 
failed to regulate E-selectin expression. In an in vitro 
model of wounding the wound front displayed an in-
crease in the number of E-selectin–expressing cells, and 
also an increase in the intensity of expression of E-selec-
tin positive cells compared to the nonwounded mono-
layer. Thus we propose that the EC junction, and in 
particular, the junctional molecule PECAM-1, is a pow-
erful regulator of endothelial adhesiveness.
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1. 
 
Abbreviations used in this paper
 
: CSF, colony stimulating factor; EC, en-
dothelial cell; HUVEC, human umbilical vein endothelial cells; ICAM-1,
intercellular adhesion molecule–1; IL-1 and IL-1ra, interleukin-1 and IL-1
receptor agonist; LPS, lipopolysaccharide; MFI, mean fluorescence inten-
sity; PECAM, platelet/endothelial cell adhesion molecule; TNF-
 
a
 
, tumor
necrosis factor-
 
a
 
; VCAM-1, vascular cell adhesion molecule–1.
 
T
 
he 
 
endothelial lining of the vascular system nor-
mally displays a nonactivated, nonadhesive pheno-
type. Stimulation with agents such as tumor necrosis
factor-
 
a
 
 (TNF-
 
a
 
)
 
1
 
, interleukin-1 (IL-1), or lipopolysaccha-
 
ride (LPS) are known to induce the expression of proteins
on the endothelial surface that mediate coagulation (Bev-
ilacqua et al., 1986), leukocyte adhesion (Bevilacqua et al.,
1985; Gamble et al., 1985; Pober et al., 1986
 
b
 
; Doherty et
al., 1989), and leukocyte transendothelial migration (Furie
et al., 1989; Moser et al., 1989). The endothelial antigens
that are important for the adhesion of leukocytes are
members of the selectin family, E- and P-selectin, and the
immunoglobulin gene superfamily, vascular cell adhesion
molecule–1 (VCAM-1) and intercellular adhesion mole-
cule–1 (ICAM-1) (Carlos and Harlan, 1994; Litwin et al.,
1995).
The induction of E-selectin expression on endothelial
cells (ECs) in vitro after cytokine stimulation is transient
and independent of the continued presence of the stimu-
lant (Pober et al., 1986
 
a
 
). Previous studies have shown that
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E-selectin mRNA and protein levels peak between 2 and 4 h,
respectively, after treatment with an agonist, returning to
near basal levels by 24 h (Bevilacqua et al., 1989; Read et
al., 1994). VCAM-1 (Osborn et al., 1989) and ICAM-1
(Pober et al., 1986
 
b
 
) are maximal 6 and 12 h, respectively,
after stimulation.
In contrast to the transiency of E-selectin and VCAM
expression demonstrated by the in vitro data, these anti-
gens have been detected on venular endothelium in chronic
inflammatory lesions, such as the synovium in rheumatoid
arthritis (Koch et al., 1991), and the skin in psoriasis (Pet-
zelbauer et al., 1994). E-selectin expression is also de-
tected on angiogenic vessels in human hemangiomas, a
noninflammatory angiogenic disease (Kraling et al., 1996).
Moreover, the architecture and anatomic localization of
capillary loops influence the pattern of endothelial expres-
sion of E-selectin and VCAM-1, independently of the
availability of cytokines (Petzelbauer et al., 1994). Thus it
is likely that alternate control mechanisms exist to allow
prolonged, locality-based expression of adhesion mole-
cules on the endothelium. At least one of these alternate
mechanisms may be flow, since increased shear stress has
been shown to selectively modulate adhesion molecule ex-
pression, upregulating ICAM-1 but not E-selectin or
VCAM-1 (Nagel et al., 1994).
Since sites of inflammation are often associated with
morphological changes including cell retraction of the en-
dothelium (Schumacher, 1973), we hypothesized that cell
contacts may be important in the regulation of endothelial
phenotype. We describe here the central role of the junc-
tional protein, platelet/endothelial cell adhesion mole-
cule–1 (PECAM-1), through the formation of cell–cell in-
teractions, in the maintenance of the functional integrity
of the endothelial monolayer. Furthermore, we demon-
strate a novel pathway for the induction of adhesion mole-
cules on endothelial cells that is independent of exogenous
addition of cytokines, but is related to integrin- and cell
shape–associated signaling events.
 
Materials and Methods
 
Cell Culture
 
ECs were extracted from human umbilical veins by collagenase treatment,
according to a modified method of Wall et al. (1978). Cells were grown in
25-cm
 
2
 
, gelatin-coated Costar flasks (Costar Corp., Cambridge, MA),
maintained with endotoxin-free medium 199 (Cytosystems, Sydney, Aus-
tralia), 20% FCS (Commonwealth Serum Laboratories, Melbourne, Aus-
tralia), 20 mM Hepes, 2 mM glutamine, 1 mM sodium pyruvate, 1% non-
essential amino acids (Cytosystems), 0.225% sodium bicarbonate and
antibiotics in the absence of exogenously added heparin or basic fibroblast
growth factor, at 37
 
8
 
C in a humidified, 5% CO
 
2
 
 (in air) atmosphere. After
2–5 d of culture, the cells were harvested by trypsin-EDTA treatment
(Cytosystems) and replated at specified cell densities on 1.9-cm
 
2
 
, gelatin-
and fibronectin-coated multiwell dishes (Nunc, Roskilde, Denmark) for
flow cytometry experiments, or on fibronectin-coated glass or Permanox
 
®
 
chamber slides (Labtek, Nunc, Roskilde, Denmark) for immunofluores-
cence and adhesion assays. The preparation of PECAM-1–transfected L
cells has been reported previously (DeLisser et al., 1993). The cells were
maintained in RPMI 1640 (GIBCO BRL, Gaithersburg, MD) 10% FCS
with 0.5 mg/ml G418.
 
Antibodies
 
Mouse mAbs directed against E-selectin (49-1B11), VCAM-1 (51-10C9),
PECAM-1 (51-9H6, 51-6F6, 55-3D2), VE-cadherin (55-7H1), integrin 
 
b
 
1
 
(61-2C4), colony-stimulating factor (CSF), common 
 
b
 
c
 
 chain (3D7, sup-
plied by Q. Sun, Hanson Centre for Cancer Research [HCCR], Adelaide,
Australia), and Keyhole Limpet Hemacyanin (23-1F11) were raised at the
HCCR. The anti–PECAM-1 mAbs were functional in an assay of neutro-
phil transendothelial migration and anti–VE-cadherin antibody was func-
tional in an assay of EC aggregation. For coating of wells with antibody,
plates were coated with rabbit anti–mouse Ig (50 
 
m
 
g/ml) for 18 h, blocked
with 1% BSA, and then anti-integrin or anti-CSF
 
b
 
c
 
 chain–purified anti-
bodies added for 1 h at 37
 
8
 
C. Wells were then washed and further blocked
before addition of cells.
 
Flow Cytometry
 
Flow cytometric analysis of in situ endothelial monolayers was performed
as previously described (Gamble et al., 1993). EC monolayers were
blocked in 5% sheep serum, and then were stained with primary antibody
for 30 min at 37
 
8
 
C, washed twice with RPMI 1640 containing 2.5% FCS,
and then stained with FITC-conjugated, anti–mouse Ig (Fab2, DAF; Sile-
nus Laboratories, Hawthorn, Australia) for 30 min at room temperature.
Cells were washed twice, removed by trypsin-EDTA treatment, and then
fixed in 1% formaldehyde, 0.02% azide, and 0.02% glucose. In experi-
ments involving endothelial pretreatment with mAbs, E-selectin was de-
tected using a single layer, FITC-conjugated, anti–E-selectin mAb (49-
1B11).
A minimum of 1,000 events per test was analyzed using an EPICS Pro-
file II (Coulter Immunology, Hialeah, FL). Results of individual EC lines
are expressed either as a plot of frequency versus log fluorescence, or as
the mean fluorescence channel number, subtracting the accompanying
value for the negative control Ig. When results from multiple EC lines
have been pooled, the mean fluorescence intensity (MFI) represents 
 
n
 
 cell
lines.
In cocultures of ECs and L cells prepared for flow cytometric analysis,
the cells were stained with anti–VE-cadherin, detected with phycoerythrin
(PE)-conjugated anti–mouse F(ab
 
9
 
)2 (DDAPE; Silenus Laboratories,
Hawthorn, Australia) and simultaneously stained with goat anti–E-selec-
tin detected with FITC–conjugated, anti–goat antibody (Silenus Labora-
tories). L cells were negative for VE-cadherin, EC were 100% positive for
VE-cadherin and were selected for analysis of E-selectin (FITC staining)
using a second fluorescence detector. The flow cytometer was calibrated
using single PE- or FITC-stained cells.
 
Immunofluorescence Confocal Microscopy
 
Confocal microscopy was performed on ECs cultured on fibronectin-
coated glass or Permanox
 
®
 
 chamber slides. A staining three layer method
was used in wounding assays and involved initial fixation in ice-cold meth-
anol for 5 min and then acetone 1 min and washing in M199-containing
2.5% FCS. Cells were stained with saturating amounts of mAb for 30 min
at 25
 
8
 
C. After two washes, cells were incubated with biotin-conjugated, af-
finity-purified anti–mouse Ig (Vector Labs, Burlingame, CA), washed
twice, and incubated with avidin-FITC (Dako Corp., Carpinteria, CA).
Slides were mounted using 2% propylgallate in glycerol as an anti-fade
agent. Images were captured with a laser scanning confocal microscope
(MRC600; Bio Rad Laboratories, Hercules, CA). Comparison images
were subjected to equivalent amounts of contrast enhancement.
 
Neutrophil–Endothelial Adhesion
 
Peripheral blood from normal volunteers was sedimented on dextran, fol-
lowed by density-gradient centrifugation on Lymphoprep (Nycomed,
Oslo, Norway) at 450 
 
g.
 
 Contaminating erythrocytes were then lysed by
hypotonic 0.2% sodium chloride. Cells were resuspended in RPMI-1640
with 2.5% FCS and yielded a purity of 
 
.
 
98%. 5 
 
3
 
 10
 
5
 
 neutrophils were
added in 125 
 
m
 
l medium to human umbilical vein endothelial cells (HU-
VECs), which had been plated 16 h earlier onto fibronectin-coated cham-
ber slides at cobblestone and subconfluent densities. After 25 min at 37
 
8
 
C
in a humidified 5% CO
 
2
 
 in air atmosphere, the wells were washed three
times removing unattached neutrophils. The slides were fixed in 0.5% glu-
taraldehyde, examined by confocal microscopy, and the number of neu-
trophils attached per EC counted. At least 160 ECs were assessed.
 
Preparation of Protein-coupled Beads
 
Tosyl-activated paramagnetic beads (Dynabeads M-450; DYNAL A.S., 
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Oslo, Norway) were coated with purified platelet PECAM-1 as previously
described (Plopper and Ingber, 1993). Essentially 99% of beads were
coated with PECAM-1 as assessed by flow cytometry using polyclonal
anti–PECAM-1 antibody staining.
 
Endotoxin Assay
 
A quantitative, photometric assay (Coatest; Kabi Diagnostica, Stockholm,
Sweden) based upon activation of a proenzyme in limulus amoebocyte ly-
sate was used, which detected endotoxin at 0.1–1.2 EU/ml.
 
Cytokines and Cytokine Antagonists
 
TNF-
 
a
 
 (lot S9010AX; sp act 6.27 
 
3
 
 10
 
7
 
 U/mg), TGF-
 
b
 
 (lot 8987-53), and a
monoclonal anti-TNF were gifts from Genentech, Inc. (South San Fran-
cisco, CA) IL-1
 
b
 
 (10
 
8
 
 thymocyte mitogenesis U/mg) was kindly supplied
by Immunex (Seattle, WA). IL-1ra was a gift from Synergen (Boulder,
CO). All cytokines contained 
 
,
 
3 U/ml of LPS.
 
Reagents and Peptides
 
Polymyxin B sulfate (Sigma Chemical Co., St. Louis, MO) was used at 10
 
m
 
g/ml. When added at plating, it effectively abolished induction of E-selectin
by LPS on ECs. Soluble PECAM-1 protein was purified from platelet and
was used at 0.01–100 
 
m
 
g/ml. Cyclic RGD and RAD peptides (EMD66203,
67679, 69601) were kindly supplied by A. Jonczyk from Merck KGaA
(Darmstadt, Germany). These peptides were identical to those used by
Brooks et al. (1994) in inhibiting 
 
a
 
v
 
b
 
3
 
-dependent angiogenesis.
 
Enumeration of EC Contacts
 
Multiple photomicrographs of low power, phase contrast fields (see Fig. 1)
were obtained of ECs plated at 0.25 and 10
 
5
 
 cells per cm
 
2
 
. The number of
cell contacts made with adjoining ECs were counted for 10 ECs per field.
 
Wounding EC Monolayers
 
ECs plated at cobblestone density on fibronectin-coated chamber slides
were wounded by scraping with the tip of a 1,000-
 
m
 
l pipette. The wells
were washed three times with medium. All wounds consisted of a clearly
demarcated cross in the center of a monolayer and healed as an advancing
front of elongated, flattened cells. At specified times after wounding, cells
were stained for immunofluorescence confocal microscopy as described
above. Phase contrast microscopy with 
 
3
 
100 magnification was used to se-
lect fields at wound fronts and on areas of cellular monolayer, at least two
fields were removed from a wound. Selected fields were then examined
with the laser confocal microscope at 
 
3
 
200 magnification and the images
stored. Images were retrieved in SETCOL format (COMOS 7.0; Bio Rad
Laboratories, Hercules, CA), which displays fluorescence intensity on a
color scale (green being minimal, red maximal), and were then examined
for the number of ECs positive and negative for E-selectin per 
 
3
 
200 field.
An EC was determined to be positive if any part of its surface, 
 
.
 
5 mm in
diam was red. At least 1,700 ECs were counted at wounds or monolayers
per well and positivity was expressed as a percentage of all cells counted.
The proportion of ECs expressing E-selectin in the top 50% range of ex-
pression intensity was assessed by analysis of pixel intensity in areas of
monolayer and wound front and calculated using the histogram format.
 
Statistics
 
The statistical significance of results was assessed using the two-tailed Stu-
dent’s 
 
t
 
 test with either paired or unpaired groups of data as indicated.
The frequency histograms of neutrophil adherence to ECs were compared
by the Kolmogorov-Smirnov test and the effects of PECAM-1–coated
beads on E-selectin expression by the analysis of variance (ANOVA) test.
 
Results
 
Confluency-dependent Expression of Endothelial 
Adhesion Molecules
 
HUVECs were seeded onto gelatin-coated tissue culture
plates at varying numbers (Fig. 1). 15 h after plating, the
EC surface expression of E-selectin was measured by flow
cytometry. Confluent, cobblestone cultures as seen in Fig.
1 
 
a
 
, showed negligible E-selectin expression (Fig. 2 
 
a
 
). This
is in agreement with published work demonstrating a lack
of E-selectin on unstimulated ECs (Pober et al., 1986
 
b
 
;
Bevilacqua et al., 1989). However, subconfluent ECs (Fig.
1 
 
b
 
) displayed substantial expression of E-selectin (Fig. 2
 
a
 
). A comparison between subconfluent and confluent
density cells using five separate EC lines showed a 17-fold
greater induction in subconfluent ECs, (6.4 
 
6
 
 1.0 vs. 0.37
 
6
 
 0.19 mean fluorescence intensity units 
 
6
 
 SEM, 
 
P 
 
5
 
0.0003, unpaired 
 
t
 
 test). In these five experiments, 57 
 
6
 
4% of ECs at subconfluent density were positive for
E-selectin, as opposed to 7 
 
6
 
 2% of cells in a cobblestone
monolayer. The confluency-dependent expression of E-selec-
tin was evident over a range of EC densities (Fig. 2 
 
b
 
) and
was seen on HUVECs extracted from their original mono-
layer culture by treatment with trypsin-EDTA or EDTA
alone (data not shown).
 
Time Course of E-selectin Expression
 
The expression of E-selectin was measured on ECs at
varying times after plating. Fig. 3 shows that cells plated at
high and low densities both displayed significant levels of
E-selectin early after plating that is within 4 to 12 h. How-
ever, expression of E-selectin on high density ECs was
fourfold less at its maximum 8 h after plating, was tran-
sient and returned to basal levels by 24 h. In contrast,
E-selectin expression on ECs plated at low density peaked
at 12 h after plating and was still evident at 32 h. ECs at
very sparse densities, such that single cells were main-
tained over the course of the experiment, displayed a per-
sistent and significant expression of E-selectin even 72 h
after plating (data not shown). There was considerable
variation in the absolute levels of E-selectin between dif-
ferent EC preparations, the reason for which is not known.
However, the fold induction calculated between high and
low density cells was relatively consistent (21.1 
 
6
 
 3.6%,
 
n
 
 
 
5
 
 30) when measured 16–20 h after plating.
VCAM-1 and ICAM-1 (as well as E-selectin) demon-
strated EC density–dependent expression, but the expres-
sion of PECAM-1 (or CD31), a non-inducible adhesion
protein was not altered (Fig. 4). Increased expression of
VCAM-1, ICAM-1, and E-selectin was independent of
cell size, as identical forward scatter gates of high and low
Figure 1. Phase contrast photomicrographs of EC monolayers 15 h
after seeding at confluent 1.0 (a), subconfluent 0.25 (b), and
sparse 0.05 3 105 cells per cm2 densities (c). Bar, 40 mm. 
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density cells were always used in the FACS
 
®
 
 analysis. Fur-
thermore, the change in adhesion molecule expression was
observed, whether the cells were stained in situ before de-
tachment, or after extraction from matrix (data not shown).
 
E-selectin Expression by Subconfluent
ECs Is Independent of Cytokines and Supports 
Neutrophil Adhesion
 
The time course of expression seen in Fig. 2 suggested two
phases in the regulation of E-selectin expression: an induc-
tion phase, and a maintenance phase. Induction of the ex-
pression of adhesion molecules by subconfluent ECs oc-
curred in the absence of exogenous cytokines. As shown in
Fig. 5 
 
a
 
, IL-1 receptor antagonist (IL-1ra) or blocking
anti–TNF-
 
a
 
 antibody potently and specifically inhibited
IL-1 or TNF-
 
a
 
–mediated induction of E-selectin, respec-
tively, but these agents were ineffective on the induction
of E-selectin by subconfluent ECs (Fig. 5 
 
b
 
). Furthermore,
conditioned medium taken from subconfluent ECs or
from cells multiply wounded such that the majority of cells
were undergoing migration, did not induce E-selectin ex-
pression on confluent density ECs (Table I). Thus a role
for endogenous endothelial cytokine production, or the re-
lease of some other stimulant from the EC, appeared un-
likely.
Further, the induction of E-selectin is not related to cell
proliferation. Rapamycin, an inhibitor of the G
 
1
 
-S transi-
tion (Kato et al., 1994) showed no effects on E-selectin in-
duction in subconfluent ECs (data not shown) although
TGF-
 
b
 
, another inhibitor of cell proliferation (Heimark et
al., 1986), which we have shown previously to inhibit cyto-
kine-induced E-selectin expression (Gamble et al., 1993)
did inhibit the cytokine-independent induction of E-selec-
tin (data not shown). Moreover, E-selectin induction was
independent of cell cycling since no difference in the level
of E-selectin expression was seen in cells in G
 
0
 
/G
 
1
 
 with re-
spect to S/G
 
2
 
/M at either cell density, both up to 20 h and
even at 72 h after EC plating (data not shown).
Low doses of TNF-
 
a
 
 were able to increase E-selectin ex-
pression on both low and high density ECs (Fig. 6 
 
a
 
) sug-
gesting that the cytokine and non-cytokine pathways of in-
duction are at least additive. Although the level of E-selectin
expression induced by the cytokine-independent mecha-
nism is less than that induced by TNF or IL-1 (Figs. 5 and
6), it is however, functionally relevant. Assessment of the
number of neutrophils adherent per EC showed that there
Figure 2. E-selectin expres-
sion varies with EC density.
(a) Flow cytometry profile
of a representative EC line
stained for E-selectin 15 h af-
ter plating. Cells were plated
at cobblestone (eee, 105
cells per cm2) or subconflu-
ent densities (thick line; 0.25 3
105 cells per cm2). (thin line)
Nonbinding control immuno-
globulin, which gave a similar
profile for confluent or sub-
confluent cells. (b) ECs were
cultured for 15 h after plating
at cell densities ranging from
sparse to confluent (0.125–
2.0  3 105 cells per cm2). The
MFI 6 SEM of E-selectin ex-
pression is shown for five EC
lines, except for values at densities 0.5 and 2.0 3 105 cells per cm2,
which are triplicates. Asterisks indicate values significantly differ-
ent (P , 0.003) from confluent density ECs (105 cells per cm2) by
unpaired t test.
Figure 3. Time course of
E-selectin expression after
EC plating. ECs were plated
at confluent (n, 105 cells per
cm2) and subconfluent (j,
0.25  3 105 cells per cm2) den-
sities. The expression of
E-selectin was assayed by
flow cytometry at specified
times after plating. The MFI
(6 SEM) of three to five cell
lines is shown but values at 2,
32, and 72 h after plating are singlicates. Asterisks denote values
significantly different between the two cell densities (P , 0.03)
by paired t test.
Figure 5. The induction of
E-selectin on subconfluent
ECs is not mediated through
TNF-a or IL-1. (a) ECs
plated at subconfluent den-
sity (0.25 3 105 cells per cm2)
were stimulated with 10 U/ml
TNF-a ( TNF) or 1 ng/ml
IL-1b (IL-1) in the presence
of anti–TNF-a (TNF 1 anti-
TNF) (1:1,000), or IL-1ra
(IL-1  1  IL-1ra) (100 ng/ml), respectively. Inhibitors and agonists
were added immediately after EC plating and E-selectin expres-
sion was assessed 12 h later. (b) ECs were plated at subconfluent
density (stripes, 0.25 3 105 cells per cm2) and confluent density
(solid, 105 cells per cm2). Anti–TNF-a or IL-1ra were added at plat-
ing. E-selectin expression was assessed 12 h later. Results shown
are of one representative experiment of four performed.
Figure 4. Expression of
E-selectin, VCAM-1, and
ICAM-1 are confluency de-
pendent. ECs plated at sub-
confluent density (stripes,
0.25  3 105 cells per cm2) and
confluent density (solid, 105
cells per cm2) were stained
20 h later for a, E-selectin, b,
VCAM-1, c, ICAM-1, or d,
PECAM-1. Expression is
shown as the MFI of 23, 11,
7, and 7 EC lines, respec-
tively. Error bars represent
the SEM. Asterisks denote
values significantly different
from cells plated at cobble-
stone density (P , 0.03) by
paired t test.Litwin et al. Cell-junctional Control of Endothelial Adhesiveness 223
was an increase in the number of neutrophils attached per
EC in cells plated at low versus high density EC (Fig. 6 b).
In three experiments, the percentage of EC supporting the
adhesion of two or more neutrophils was 24.3% 6 14% for
low density EC and 1.4% 6 1.0% for high density EC
(mean  6 SEM; P 5 0.02).
E-selectin Induction Is Dependent on
Integrin Engagement
ECs plated on collagen 1, gelatin, fibronectin, fibrinogen,
and laminin in BSA-containing media resulted in an up-
regulation of E-selectin when measured 6 h after plating
(Fig. 7 a). The level of induction on these matrices in the
absence of FCS in the media was never as high as in the
presence of FCS. E-selectin expression was not induced on
ECs plated on poly-l-lysine (Fig. 7 a) although they re-
sponded to TNF stimulation, suggesting that the poly-
l-lysine was not toxic (data not shown). The induction was
seen whether cells were plated at subconfluent density
(Fig. 7) or at high density (data not shown). Cells plated
on anti–b1 integrin-coated surfaces, attached, spread, and
induced E-selectin. In contrast, cells plated on an antibody
to the common b chain (bc) of GM-CSF, IL-3, and IL-5 re-
ceptor, which is also expressed on EC (Korpelainen et al.,
1993), attached but failed to spread and also did not result
in E-selectin induction (data not shown). Cells plated on
fibrinogen in the presence of cyclic RGD peptide also
failed to induce E-selectin (Fig. 7 b) although the peptide
had no effect on E-selectin expression on cells plated on
collagen (data not shown). These results suggest integrin
engagement and possibly cell shape changes also are im-
portant in E-selectin induction.
PECAM-1 Regulates the Maintenance of Endothelial 
Adhesion Molecules
Although E-selectin is induced on all cells, only subconflu-
ent EC maintain this expression. The chief difference be-
tween these density phenotypes lies in the number of cell–
cell contacts and their establishment rate. ECs plated at
confluent density (105 cells per cm2) were rapidly sur-
Table I. E-selectin Expression Is Not Stimulated by 
Supernatant from Migrating Endothelial Cells
Addition MFI
Unwounded SN 0.01 6 0.01
6 h SN 0.04 6 0.04
24 h SN 0.02 6 0.02
TNF (10 U/ml) 20.5 6 5.9
A confluent EC monolayer was multiply wounded such that all cells in the well were
induced to migrate. The cells were washed twice to remove debris and replaced with
fresh medium. Supernatants (SNs) were collected at 6 and 24 h thereafter and added to
other wells containing confluent EC. TNF (10 U/ml) was added to some of these wells
as a control, and E-selectin expression measured 4 h later. The results are given as the
MFI 6 SEM of two experiments. Neither the 6 nor the 24 SN gave significant in-
creases in E-selectin expression compared to SN from unwounded cells. 
Figure 6. The non–cytokine-mediated pathway of E-selectin ex-
pression is additive with TNF-induced E-selectin expression and
supports neutrophil adherence. (a) E-selectin expression on ECs
plated at cobblestone density (105 cells per cm2) or subconfluent
densities (0.25 3 105 cells per cm2) 15 h after plating (black). In
some groups 1 U/ml of TNF-a was added 4 h before analysis
(gray). Results shown are the mean 6 SEM of four EC lines. Dif-
ferences between non–cytokine-induced expression and expres-
sion after TNF stimulation, were significant by paired t test (P 5
0.04, confluent density ECs and P 5 0.02 subconfluent density
ECs). (B) 15 h after plating EC at either confluent (solid, 105 cells
per cm2) or subconfluent densities (stripes, 0.25 3 105 cells per
cm2) neutrophils were added. 30 min later, attached neutrophils
were removed by gentle washing and the number of neutrophils
adherent per EC were counted using microscopy. A plot of the
distribution frequency is shown. 176 ECs at cobblestone density
and 168 ECs at subconfluent density were counted in the experi-
ment shown, which is representative of at least three experi-
ments. The two groups were statistically different (P 5 0.01) by
the Kolmogorov-Smirnov test.
Figure 7. Integrin engagement is critical for E-selectin induction.
(a) ECs were plated onto multiwell dishes coated with 0.2% gela-
tin (Gel.) or 50 mg/ml of fibrinogen (Fg.), collagen 1 (Col. 1), fi-
bronectin (Fn.), laminin (Ln.), or poly-l-lysine (P-L-L) for 2 h.
The cells were plated at a density of 0.25 3 105 cells per cm2 in
1% BSA without added FCS. Cells were stained with anti–E-selec-
tin or control antibody 6 h later and results given as the mean 6
SEM of triplicate determinations from one experiment, which is
representative of at least three similar experiments. The back-
ground level of staining of cells on each matrix, using a nonbind-
ing antibody has been subtracted. Asterisks denote values signifi-
cantly different from control group, which was stained with
nonbinding antibody (P , 0.002). (b) EC at subconfluent density
(0.25 3 105 cells per cm2) were plated onto fibrinogen-coated
wells in the presence of cyclic RGD (Arg-Gly-Asp) or RAD
(Arg-Ala-Asp) peptides (final concentration 10 mM) in 1% BSA-
containing media. E-selectin expression was measured 6 h after
plating and is given as the mean 6 SEM of a representative ex-
periment where each group was performed in triplicate. Asterisks
denote values significantly different from control peptide (P ,
0.01).The Journal of Cell Biology, Volume 139, 1997 224
rounded by other cells. Within 1 h they had established
5 6 1 contacts with adjoining cells (mean 6 SEM; n 5 3).
This number remained constant over the following 24 h.
By contrast, subconfluent ECs (0.25 3 105 cells per cm2)
had an average of only 1 6 1 contact (n 5 3) at 1 h after
plating and continued to form new associations such that
24 h later they had 4 6 1 contacts (n 5 6).
Two molecules known to be concentrated in cell–cell
contacts and implicated in establishment of some of the
junctional properties of endothelial cell monolayers are
PECAM-1 (Albelda et al., 1991; DeLisser et al., 1994) and
VE-cadherin (Lampugnani et al., 1992; Ayalon et al.,
1994). To determine whether PECAM-1 was involved in
the cytokine-independent regulation of E-selectin, three
independent methods were used. Firstly, confluent density
EC monolayers were exposed to functional antibodies di-
rected to PECAM-1 or VE-cadherin. Monoclonal anti–
VE-cadherin antibody (antibody 7H1) had no effect. Poly-
clonal anti–PECAM-1 resulted in a twofold increase in
E-selectin expression (Fig. 8, a and b). Addition of both
anti–PECAM-1 and anti–VE-cadherin antibodies pro-
duced no further increase than with anti–PECAM-1 anti-
body alone (data not shown). Although two mAb directed
to domain one of PECAM-1 consistently and significantly
enhanced E-selectin expression their activity was always
less than that seen with the polyclonal anti–PECAM-1 an-
tibody (Fig. 8 b) suggesting the involvement of multiple
domains. 55-3D2, an mAb directed to domain two-thirds
of PECAM-1 was without function in these assays al-
though it inhibits neutrophil transendothelial cell migra-
tion (Yan et al., 1995). The anti–PECAM-1 antibody ef-
fect was dose dependent (maximal efficacy at 5 mg/ml) and
not due to contaminating endotoxin as polymyxin B did
not abrogate the enhancement, the antibodies did not
Figure 8. Anti–PECAM-1 antibody upregulates E-selectin on
ECs plated at cobblestone density. (a) ECs at cobblestone den-
sity (105 cells per cm2) were treated with Ig-purified rabbit poly-
clonal antibody to PECAM-1 (5 mg/ml) or a control nonimmune
rabbit Ig at the time of plating. E-selectin expression was assessed
by flow cytometry 12 h later. The MFI (6 SEM ) of two to six ex-
periments is given where untreated confluent density ECs have
been normalized to 1.0. Subconfluent ECs showed a 5.1 6 1.4-
fold increase in E-selectin expression relative to confluent EC.
Asterisks denote a significant difference (P , 0.05) compared
with control rabbit Ig by unpaired t test. (b) ECs at confluent
density were treated with 5 mg/ml Ig-purified mAbs to PECAM-1
or VE-cadherin at the time of plating or polyclonal anti–PECAM-1
antibody. E-selectin expression was measured 12 h later. The
MFI (6 SEM) of three experiments is given where untreated
confluent density ECs have been normalized to 1.0. Subconfluent
ECs showed a 4.0 6 0.7-fold relative increase in E-selectin ex-
pression relative to confluent EC. Asterisks denote a significant
difference (P , 0.05) compared with cobblestone EC group.
Figure 9. Adhesion through PE-
CAM-1–coated beads down-
regulates E-selectin. ECs at sub-
confluent density (0.25 3 105
cells per cm2) were plated in the
absence or presence of beads
(20 beads per cell) coated either
with purified PECAM-1 or the
blocking agent (BSA) alone.
Cells at high density (105 cells
per cm2) were also plated. E-selec-
tin expression was measured 18 h
after plating. The data represents three experiments where each
group was performed in triplicate and is presented relative to the
E-selectin expression on subconfluent ECs, which is shown as
100%. (The mean MFI at 100% was 2.01 6 0.09.) Asterisk indi-
cates where PECAM-1–coated beads significantly decreased
E-selectin (P , 0.001 by ANOVA) compared to BSA-coated
beads.
Figure 10. PECAM-1–transfected
L cells regulate E-selectin ex-
pression. (a) EC at subconfluent
density (0.2 3 105 cells per cm2)
were plated in the presence or
absence of various concentra-
tions of PECAM-1–transfected L
cells (s, full-length PECAM-1;
h, domain 2 deletion mutant; n,
untransfected L cells). EC were
also plated at high density (r).
A ratio of 1 EC to 8 L cells
would be equivalent in cell num-
ber to a high density culture of
EC. 18 h later, cells were har-
vested and stained with goat
anti–E-selectin polyclonal anti-
body and detected using an
anti–goat labeled polyclonal an-
tibody together with a mouse
anti–VE-cadherin antibody and
detected with an anti–mouse,
FITC-conjugated antibody. Cells were analyzed by two color
analysis, and only the fluorescein positive (i.e., EC) were ana-
lyzed for E-selectin expression. The results are given as the MFI
of one representative experiment of at least four performed
where a similar trend was seen in each. (b) Subconfluent EC
were plated as in a but either the full-length, PECAM-1 L cell
transfectants (s), or cytoplasmic tail deletion mutant (X). Anal-
ysis was as for a and is given as the MFI of a representative ex-
periment of at least four performed.Litwin et al. Cell-junctional Control of Endothelial Adhesiveness 225
have detectable endotoxin and boiling the antibody abol-
ished its potency (Fig. 8 a). VCAM-1 was also upregulated
on cobblestone ECs by polyclonal anti–PECAM-1 anti-
body by 1.7 6 0.19-fold (mean 6 SEM, n 5 3, P 5 0.03,
paired t test).
The second approach used platelet purified PECAM-1
immobilized on beads. E-selectin expression on EC plated
at low density in the presence of PECAM-1–coated beads
was inhibited when measured 18 h after plating (inhibition
was 61 6 20%; n 5 3). BSA-coated beads had no effect
(Fig. 9). Interestingly, neither purified, soluble PECAM-1,
nor its immobilization on plastic was able to regulate E-selec-
tin expression (data not shown) suggesting that valency,
concentration, or microenvironment problems may be op-
erating.
The third approach used PECAM-1 transfectants. EC
were plated at subconfluent density in the presence of L
cells expressing full-length PECAM-1, PECAM-1 lacking
domain 2, or lacking the cytoplasmic tail. Both the full
length and the truncation of the cytoplasmic tail inhibited
E-selectin expression, whereas the mutant lacking domain
2 had no effect (Fig. 10 a). Untransfected L cells (Fig. 10 b)
or L cells expressing the L1 adhesion glycoprotein (a
member of the Ig superfamily expressed by neural cells
and lymphocytes (Hubbe et al., 1993) failed to regulate
E-selectin expression.
E-selectin Is Upregulated at Endothelial
Wound Edges Whereas the Cell Junctional Molecule
PECAM-1 Is Diminished
An in vitro wound assay was established as an in vivo cor-
relate of EC migration (Schimmenti et al., 1992; Taylor
and Alexander, 1993). ECs were plated and allowed to
come to confluence. At variable times thereafter wounds
were made and the cells stained 11 and 27 h later for
E-selectin and PECAM-1. As seen in Fig. 11 b, the cells at
the wound front displayed a spread, motile, morphology,
and had advanced beyond the wound edge. These migrat-
ing cells had less PECAM-1 staining at the cell-to-cell bor-
ders. Significantly more ECs at the wound front and imme-
diately behind the front expressed E-selectin in comparison
Figure 11. Immunofluorescence confocal microscopy of wounded ECs 40 h after plating and 11 h after wounding. a and c are cobblestone
monolayers distant from the wound front. b and d are ECs at wound edges. a and b are stained for PECAM-1, whereas c and d are
stained for E-selectin. b and d are not the same area but are of representative areas along the migrating front. The wound front is
marked with a vertical bar. Bar, 40 mm.The Journal of Cell Biology, Volume 139, 1997 226
to the nonwounded areas (Fig. 11, c and d), and this was
substantiated by direct counts of the number of E-selectin
expressing cells (Table II). The proportion of ECs express-
ing E-selectin in the top 50% range of intensity of expres-
sion was 1.7 6 0.7% in the cell monolayer compared to 16
6 5.0% at the wound front (mean 6 SEM of three sepa-
rate experiments at 16 h after wounding; P 5 0.05).
Discussion
In this article, we have demonstrated a novel mechanism
for the induction and expression of adhesion molecules on
ECs. The induction is initiated through an integrin-depen-
dent process and is associated with cell spreading. The in-
tensity and duration of expression of the adhesion mole-
cules is inversely proportional to cell density, and is
mediated at least in part through the junctional protein,
PECAM-1. This phenomenon does not involve the known
cytokines and differs from the cytokine-dependent path-
ways in a number of ways: (a) it is dependent on integrin
engagement and cell shape; (b) it is regulated by cell junc-
tions; and (c) it can result in prolonged cell surface expres-
sion of adhesion molecules (Table III).
Since the phenomena described in this paper represent
a fundamentally new mechanism underlying important
pathological processes, we suggest nomenclature where
type I induction refers to the classic cytokine-dependent
process, and type II induction refers to the new cytokine-
independent pathway. Although the level of E-selectin in-
duced in type II conditions is less than that seen for maxi-
mal doses of cytokine-induced E-selectin, it is functional
as evidenced by increased neutrophil attachment, and is at
least additive with low doses of TNF. Such situations of
low cytokine concentrations may be relevant during early
phases of inflammatory lesions, suggesting the potential
importance of both these induction processes in determin-
ing endothelial phenotype.
Type II induction of E-selectin described herein is inde-
pendent of cell size, cell proliferation, and cell cycle, but is
initially integrin mediated and seen in cells plated at both
high and low density. Cells plated onto ligands that facili-
tated integrin-mediated attachment induce E-selectin ex-
pression (Fig. 7). However if the initial attachment is
blocked, as with the addition of cyclic RGD peptides to
cells on fibrinogen, E-selectin induction is inhibited. Bind-
ing of RGD to cells per se is insufficient to inhibit E-selec-
tin induction since RGD peptides have no effect on cells
plated onto collagen.
The intensity and duration of induction of type II re-
sponses was related to the density of cell plating. Cells
plated at confluent density expressed less E-selectin when
measured 8–48 h after plating, compared to cells plated at
subconfluent density (Fig. 3). Morphologically, cells plated
at high density form rapid cell–cell interactions in contrast
to low density cells. Thus, junctional control of EC adhe-
sion molecule expression was considered. Two molecules
have been described that are known to be important in en-
dothelial junctional integrity (Albelda et al., 1991; Lam-
pugnani et al., 1992; Ayalon et al., 1994; DeLisser et al.,
1994): PECAM-1, a transmembrane glycoprotein belong-
ing to the Ig gene superfamily containing six extracellular,
Ig-like domains; and VE-cadherin, an endothelium-spe-
cific member of the cadherin family of cell junctional mol-
ecules. The involvement of PECAM-1 in the control of
E-selectin expression was shown by three independent
methods. Firstly, anti–PECAM-1 but not anti–VE-cad-
herin antibodies induced E-selectin expression on conflu-
ent ECs (Fig. 8). Although the increases achieved with the
antibodies were not to the level seen on low density cells,
they were consistent. This may suggest that molecules
other than PECAM-1 could exert secondary events that
influence the level of expression of E-selectin. Secondly,
PECAM-coated beads, when added at plating, inhibited
the level of E-selectin expression on low density cells com-
pared to BSA-coated beads (Fig. 9). Thirdly, transfectants
expressing full-length PECAM-1, or those expressing the
extracellular domains but lacking the cytoplasmic domain,
inhibited E-selectin expression on subconfluent ECs (Fig.
10). In contrast, L cells expressing the domain 2 deletion
mutant failed to effect E-selectin expression, suggesting a
critical involvement of domain 2 in this regulation. These
results are in agreement with other studies showing the
importance of domain 2 in cell aggregation (Sun et al.,
1996). Together with our antibody studies showing that
antibodies to domain 1 increased the level of E-selectin
expression on high density cells, our results suggest that
both domains 1 and 2 of PECAM-1 are critical in regula-
tion of E-selectin expression.
Cell–cell interactions are known to regulate a number of
events, including cell proliferation (Gradl et al., 1995), re-
lease of bFGF from astrocytes (Murphy et al., 1988), re-
sponsiveness of fibroblasts to TGF-b (Paulsson et al.,
1988), and the regulation of intracellular pH (Galkina et
al., 1995). The mechanisms that underlie such regulation
however have not been elucidated, although autocrine re-
lease of growth inhibitory factors (Antonelli-Orlidge et al.,
1989; Gradl et al., 1995) and gap junction changes (Chen et
Table II. E-selectin Expression by ECs at Wound Edges
Time after
wounding E-selectin–positive ECs
Mean increase in number of
E-selectin–positive ECs (n 5 3)
%
Monolayer Wound front
11 h 4.1 13.5 2.2 6 0.5
27 h 4.3 10.4 2.4 6 0.5
Confluent EC monolayers were wounded by scraping with a pipette tip at either 13 or
29 h after plating. The cells were stained for E-selectin 27 or 11 h thereafter, respec-
tively (i.e., 40 h after plating). An average of 2,600 cells was counted in the confluent
monolayer, and 1,700 at the wound edge for each experiment, and the E-selectin–pos-
itive cells was calculated as described in Materials and Methods. The percent of posi-
tive cells at either the wound front or in the monolayer in a single experiment (n 5 1)
is shown. Also shown is the mean increase in the number of positive cells at the
wound front compared to the monolayer for three experiments where all experiments
showed the same trend.
Table III. Mechanisms Controlling Expression of Endothelial 
Adhesion Molecules
Type I Type II
Induction Cytokine, endotoxin Integrin, cell shape
Peak 4–6 h 8–12 h
Duration Transient Prolonged
Regulation Receptor mediated Cell junctionsLitwin et al. Cell-junctional Control of Endothelial Adhesiveness 227
al., 1995) have been proposed. As described here, a cell
surface junctional protein, PECAM-1, plays a central role
in the density-dependent regulation of endothelial E-selectin
expression. The possibility of a signaling role for PECAM-1
has been raised previously in a number of different sys-
tems. These include activation of integrins on T cells
(Tanaka et al., 1992), natural killer cells (Berman et al.,
1996), monocytes and neutrophils (Berman and Muller,
1995), and on CD341 hematopoietic progenitor cells
(Leavesley et al., 1994), inhibition of EC proliferation
(Fawcett et al., 1995), and platelet aggregation (Newman
et al., 1992). The association of the tyrosine phosphatase-
SHP2 with aggregated platelets (demonstrated recently by
Jackson et al. [1997]) has put credence to a signaling path-
way associated with PECAM-1 itself. Of interest to our
study here is the recent observation by Lu et al. (1996) that
integrin engagement and cell spreading results in PECAM-1
dephosphorylation in EC. Thus, the likely cross-talk be-
tween integrin and PECAM-1 is further strengthened.
Our in vitro model of cell wounding displays similar fea-
tures to that described in the density-dependent regulation
of adhesion molecules. Firstly, the induction of E-selectin
expression is restricted to the migrating front and is associ-
ated with a change in cell shape and PECAM-1 redistribu-
tion away from the cell junction. Secondly, the E-selectin
expression on these migrating cells is maintained at least
up to 30 h after the wound signal. Thus we would suggest
that this model may reflect identical signaling pathways as
those operating in our plating experiments, and may there-
fore be appropriate as a model for in vivo endothelial reg-
ulation at wound sites.
Pathological tissue inflammation is characterized by in-
creased and chronic expression of endothelial adhesion
molecules (Koch et al., 1991; Petzelbauer et al., 1994; Kral-
ing et al., 1996), changes in endothelial morphology and
angiogenesis (Fitzgerald et al., 1991). These morphological
changes include the formation of high endothelial venules
(Freemont et al., 1983) and cell retraction with associated
intercellular gaps (Nagel et al., 1994). In balloon angio-
plasty, expression of adhesion molecules at the wound
front associated with morphological changes has been ob-
served in contrast to the lack of expression in the area be-
hind the wound edge (Tanaka et al., 1993). More recently,
a role for E-selectin in angiogenesis has been postulated
(Nguyen et al., 1993; Koch et al., 1995; Kraling et al.,
1996). The results reported here, demonstrate: (a) a cyto-
kine-independent mechanism of adhesion molecule ex-
pression, and (b) that cell–cell interactions influence the
duration and magnitude of this expression, may explain
some of these in vivo observations. Furthermore, the ob-
servation that restoration of PECAM-1 interactions can
downregulate adhesion molecule expression on ECs offers
the promise that manipulation of EC junctional molecules
may permit the development of novel therapeutics.
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